Abstract:Importance: Social and occupational impairments contribute to the burden of psychosis and depression. There is a need for risk stratification tools to inform personalized functional-disability preventive strategies for individuals in at-risk and early phases of these illnesses. Objective: To determine whether predictors associated with social and role functioning can be identified in patients in clinical high-risk (CHR) states for psychosis or with recent-onset depression (ROD) using clinical, imaging-based, and combined machine learning; assess the geographic, transdiagnostic, and prognostic generalizability of machine learning and compare it with human prognostication; and explore sequential prognosis encompassing clinical and combined machine learning. Design, setting, and participants: This multisite naturalistic study followed up patients in CHR states, with ROD, and with recent-onset psychosis, and healthy control participants for 18 months in 7 academic early-recognition services in 5 European countries. Participants were recruited between February 2014 and May 2016, and data were analyzed from April 2017 to January 2018. ain outcomes and measures: Performance and generalizability of prognostic models. Results: A total of 116 individuals in CHR states (mean [SD] age, 24.0 [5.1] years; 58 [50.0%] female) and 120 patients with ROD (mean [SD] age, 26.1 [6.1] years; 65 [54.2%] female) were followed up for a mean (SD) of 329 (142) days. Machine learning predicted the 1-year social-functioning outcomes with a balanced accuracy of 76.9% of patients in CHR states and 66.2% of patients with ROD using clinical baseline data. Balanced accuracy in models using structural neuroimaging was 76.2% in patients in CHR states and 65.0% in patients with ROD, and in combined models, it was 82.7% for CHR states and 70.3% for ROD. Lower functioning before study entry was a transdiagnostic predictor. Medial prefrontal and temporo-parieto-occipital gray matter volume (GMV) reductions and cerebellar and dorsolateral prefrontal GMV increments had predictive value in the CHR group; reduced mediotemporal and increased prefrontal-perisylvian GMV had predictive value in patients with ROD. Poor prognoses were associated with increased risk of psychotic, depressive, and anxiety disorders at follow-up in patients in the CHR state but not ones with ROD. Machine learning outperformed expert prognostication. Adding neuroimaging machine learning to clinical machine learning provided a 1.9-fold increase of prognostic certainty in uncertain cases of patients in CHR states, and a 10.5-fold increase of prognostic certainty for patients with ROD. Conclusions and relevance: Precision medicine tools could augment effective therapeutic strategies aiming at the prevention of social functioning impairments in patients with CHR states or with ROD.

The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy

Protein-protein Interaction Network with Machine Learning Models and Multiomics Data Reveal Potential Neurodegenerative Disease-Related Proteins

Prediction Model for Polyneuropathy in Recent‐Onset Diabetes Based on Serum Neurofilament Light Chain, Fibroblast Growth Factor‐19 and Standard Anthropometric and Clinical Variables

Evaluating Performance of Machine Learning Models for Diabetic Sensorimotor Polyneuropathy Severity Classification using Biomechanical Signals during Gait

Longitudinal artificial intelligence-based deep learning models for diagnosis and prediction of the future occurrence of polyneuropathy in diabetes and prediabetes

A machine learning-based severity prediction tool for diabetic sensorimotor polyneuropathy using Michigan neuropathy screening instrumentations

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Interpretable Machine Learning on Metabolomics Data Reveals Biomarkers for Parkinson’s Disease

A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

Associations between multiple neurological biomarkers and distal sensorimotor polyneuropathy: KORA F4/FF4 study

Optimizing Parkinson's Disease Diagnosis with Multimodal Data Fusion Techniques

Explainable Deep Learning to Profile Mitochondrial Disease Using High Dimensional Protein Expression Data

Interpretable machine learning models for detecting peripheral neuropathy and lower extremity arterial disease in diabetics: an analysis of critical shared and unique risk factors

Probabilistic prediction of neurological disorders with a statistical assessment of neuroimaging data modalities

A robust and interpretable machine learning approach using multimodal biological data to predict future pathological tau accumulation

Disability prediction in multiple sclerosis using performance outcome measures and demographic data

Enhancing early Parkinson's disease detection through multimodal deep learning and explainable AI: insights from the PPMI database

Identifying Multimodal Intermediate Phenotypes Between Genetic Risk Factors and Disease Status in Alzheimer's Disease

Leveraging the Potential of Digital Technology for Better Individualized Treatment of Parkinson's Disease

Interpretable Deep Learning for the Remote Characterisation of Ambulation in Multiple Sclerosis using Smartphones